Average Co-Inventor Count = 3.30
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Tris Pharma, Inc. (18 from 53 patents)
2. Tulex Pharmaceuticals Inc. (7 from 7 patents)
25 patents:
1. 12343372 - Desmopressin oral compositions
2. 12290503 - Compositions and methods for treating epilepsy, seizures and other conditions
3. 12214010 - Desmopressin oral compositions
4. 11911362 - Compositions and methods for treating epilepsy, seizures and other conditions
5. 11826343 - Compositions and methods for treating epilepsy, seizures and other conditions
6. 11633374 - Compositions and methods for treating epilepsy, seizures and other conditions
7. 11633389 - Methylphenidate extended release chewable tablet
8. 11433046 - Compositions and methods for treating epilepsy, seizures and other conditions
9. 11103494 - Methylphenidate extended release chewable tablet
10. 11103495 - Methylphenidate extended release chewable tablet
11. 10857143 - Methylphenidate extended release chewable tablet
12. 10507203 - Methylphenidate extended release chewable tablet
13. 9844544 - Methylphenidate extended release chewable tablet
14. 9844545 - Methylphenidate extended release chewable tablet
15. 9545399 - Methylphenidate extended release chewable tablet